Armata Pharmaceuticals Analyst Ratings
Armata Pharmaceuticals Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 44.63% | HC Wainwright & Co. | $7 → $7 | Reiterates | Buy → Buy |
| 05/12/2023 | 44.63% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 03/17/2023 | 44.63% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 03/07/2023 | 44.63% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 03/22/2021 | 44.63% | HC Wainwright & Co. | $5 → $7 | Maintains | Buy |
| 05/15/2020 | 3.31% | HC Wainwright & Co. | $9 → $5 | Reiterates | → Buy |
| 03/20/2020 | 85.95% | HC Wainwright & Co. | $9.5 → $9 | Reiterates | → Buy |
| 02/06/2020 | 65.29% | Maxim Group | → $8 | Initiates Coverage On | → Buy |
| 06/19/2019 | 85.95% | Ladenburg Thalmann | → $9 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年08月14日 | 44.63% | HC Wainwright公司 | $7→$7 | 重申 | 购买→购买 |
| 2023年05月12日 | 44.63% | HC Wainwright公司 | →$7 | 重申 | 购买→购买 |
| 03/17/2023 | 44.63% | HC Wainwright公司 | →$7 | 重申 | →购买 |
| 03/07/2023 | 44.63% | HC Wainwright公司 | →$7 | 重申 | →购买 |
| 03/22/2021 | 44.63% | HC Wainwright公司 | $5→$7 | 维护 | 买 |
| 2020/05/15 | 3.31% | HC Wainwright公司 | $9→$5 | 重申 | →购买 |
| 03/20/2020 | 85.95% | HC Wainwright公司 | $9.5→$9 | 重申 | →购买 |
| 02/06/2020 | 65.29% | Maxim集团 | →$8 | 开始承保 | →购买 |
| 2019年6月19日 | 85.95% | 拉登堡·塔尔曼 | →$9 | 开始承保 | →购买 |
What is the target price for Armata Pharmaceuticals (ARMP)?
Armata PharmPharmticals(ARMP)的目标价是多少？
The latest price target for Armata Pharmaceuticals (AMEX: ARMP) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $7.00 expecting ARMP to rise to within 12 months (a possible 44.63% upside). 4 analyst firms have reported ratings in the last year.
2023年8月14日，HC Wainwright&Co.报道了Armata制药公司(美国证券交易所代码：ARMP)的最新目标价。这家分析公司将目标价定为7.00美元，预计ARMP将在12个月内上涨至44.63%。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Armata Pharmaceuticals (ARMP)?
分析师对Armata制药公司(ARMP)的最新评级是多少？
The latest analyst rating for Armata Pharmaceuticals (AMEX: ARMP) was provided by HC Wainwright & Co., and Armata Pharmaceuticals reiterated their buy rating.
分析师对Armata制药公司(美国证券交易所代码：ARMP)的最新评级是由HC Wainwright&Co.提供的，Armata制药公司重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Armata Pharmaceuticals (ARMP)?
Armata PharmPharmticals(ARMP)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Armata Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Armata Pharmaceuticals was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Armata制药公司的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Armata制药的上一次评级是在2023年8月14日提交的，所以你应该预计下一次评级将在2024年8月14日左右的某个时候公布。
Is the Analyst Rating Armata Pharmaceuticals (ARMP) correct?
分析师对Armata PharmPharmticals(ARMP)的评级正确吗？
While ratings are subjective and will change, the latest Armata Pharmaceuticals (ARMP) rating was a reiterated with a price target of $7.00 to $7.00. The current price Armata Pharmaceuticals (ARMP) is trading at is $4.84, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Armata制药(ARMP)评级被重申，目标价在7.00美元至7.00美元之间。Armata PharmPharmticals(ARMP)目前的交易价格为4.84美元，超出了分析师的预测区间。